Czy „cichy” polimorfizm pojedynczego nukleotydu (SNP) C1236T genu ABCB1 jest związany z predyspozycją do rozwoju depresji i skutecznością jej leczenia? - badanie wstępne
Journal Title: Folia Medica Lodziensia - Year 2014, Vol 41, Issue 1
Abstract
Introduction: According to the World Health Organization about 350 million people around the world are affected by depression. Despite the high prevalence of this disease the mechanism of depression origination as well as the causes of the resistance to therapy are still not fully understood. ABCB1 gene encode P glycoprotein which is one of the components of blood-brain barrier. The main function of this protein is the efflux of many toxic compounds, including drugs, which may indicate potential association between the proper functioning of P glycoprotein and the susceptibility to the development of depressive disorders or the failure of antidepressant therapy. The objective of this study was to evaluate single nucleotide polymorphism (SNP) C1236T of the ABCB1 gene in the group of patients with recurrent depressive disorder (rDD) and to estimate the possible association of this polymorphism with the response to antidepressant therapy. Material and methods: C1236T was evaluated in 30 patients with rDD. Genotyping was performed using automated sequencing (the Sanger method). The results were compared with those obtained from the control group which consisted of 96 blood donors from the local blood bank. Results: No statistically significant difference in the frequency of genotypes (p=0.0665) and allele (p=0.1489) for the SNP C1236T of ABCB1 gene was found between the patients with rDD and the control group. No correlation between C1236 and the age when the disease was stated (p=0.0807). Neither the association between genotypes and the severity of depressive symptoms before treatment (p=0.7956) nor the association with effectiveness of the therapy (p=0.2051) were found. Conclusions: On the basis of the results of the preliminary study, C1236T of ABCB1 gene have no influence on the predisposition to rDD, the severity of depressive symptoms and the efficiency of antidepressant therapy have not been stated, either.
Authors and Affiliations
Aleksandra Sałagacka, Anna Koziróg, Agnieszka Jeleń, Piotr Gałecki, Ewa Balcerczak, Monika Talarowska
Keywords
Related Articles
- EP ID EP168860
- DOI -
- Views 92
- Downloads 0
Zmiany czynności mioelektrycznej żołądka u osób z depresją i objawami dyspeptycznymi
Introduction: A chronic or recurrent pain and discomfort in the upper abdomen occurs frequently in depressive patients. The pathogenesis of these symptoms is complex and not fully understood. The aim of the study was to...
Analysis of polymorphisms / mutations of PTEN, CDKN2A, TP53 genes and of hMSH6 gene in endometrial hyperplasia and carcinoma
Endometrial cancer belongs to the most frequent malignancies in the female genital organs with a growing incidence trend. The molecular changes, which are specific for particular stages of neoplastic transformation or th...
Neuroendokrynologia doświadczalna i jej implikacje kliniczne – historia i perspektywy
Neuroendocrinology is an interdisciplinary field of the biomedical science exploring structural and functional relation between two systems: nervous and endocrine. We distinguish experimental neuroendocrinology and its c...
Udział zaburzeń szlaku FGF/FGFR w transformacji nowotworowej piersi, jajnika oraz błony śluzowej trzonu macicy
Fibroblast growth factors (FGFs) and their receptors (FGFRs) are the members of a large protein family involved in the regulation of many cellular processes which are essential for proper functioning of cells. It was fou...
Biochemiczna ocena skuteczności leczenia pacjentów z akromegalią
Introduction: The main treatment for acromegaly is the surgical removal of the tumour. Pharmacotherapy, usually with somatostatin analogues (SSA), is used as the preliminary and/or complementary therapy. In the diagnosis...